Anti-Emetics Segment To Fuel The Growth Of Nausea Medicine Market

Lucy Kart

Anti-Emetics Segment To Fuel The Growth Of Nausea Medicine Market

The global Nausea Medicine Market is estimated to be valued at US$ 7.52 Bn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Nausea medicine commonly known as anti-emetics are used to reduce nausea and vomiting caused due to chemotherapy, motion sickness, and gastro-intestinal infections and illness. Anti-emetics help in reducing nausea and aid digestion by blocking nausea-triggering receptors in the brain.

Market key trends:

One of the key trends fueling the growth of the nausea medicine market is increasing prevalence of cancer and growing number of surgeries associated with it. Chemotherapy is one of the major treatment modes for cancer but it often leads to severe nausea and vomiting. According to the World Health Organization (WHO), cancer burden is expected to grow to 27 million new cases and 17 million cancer deaths by 2030. Rising prevalence of cancer will subsequently increase demand for nausea medicines especially anti-emetics for chemotherapy-induced nausea and vomiting (CINV) over the forecast period.

Segment Analysis

The global nausea medicine market is segmented into treatments and geography. Based on treatments, the market is segmented into antihistamines, anticholinergics, and antiemetics. The antiemetics segment currently dominates the market due to the rising prevalence of nausea and vomiting due to medication, pregnancy, or post-surgery. Within antiemetics, 5-HT3 receptor antagonists and NK1 receptor antagonist drugs together hold the major market share owing to their effectiveness in preventing nausea and vomiting.

Key Takeaways

Global Nausea Medicine Market Demand is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing prevalence of gastrointestinal disorders. The global nausea medicine market size is expected to reach US$ 7.52 Bn by 2023.

Regionally, North America is expected to dominate the nausea medicine market over the forecast period owing the high prevalence of nausea and vomiting in this region. Europe holds the second position in the nausea medicine market.

Key players operating in the nausea medicine market are GlaxoSmithKline plc, Pfizer Inc., Novartis International AG, Sanofi S.A., Merck & Co., Inc., Johnson & Johnson, Bayer AG, Takeda Pharmaceutical Company Limited, AstraZeneca plc, Eli Lilly and Company. GlaxoSmithKline plc and Pfizer Inc. together hold around 30% of the total market share.

Lucy Kart

The Emergence Of Targeted Triple Combination Therapies To Boost Growth Of The Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market

Mia Yates 2023-12-11

The Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market is estimated to be valued at US$ 3,071. Porter’s Analysis: Threat of new entrants: The cancer chemotherapy associated nausea and vomiting therapeutics market poses a low threat of new entrants due to high R&D and capital requirements. SWOT Analysis: Strengths: The cancer chemotherapy associated nausea and vomiting therapeutics market possesses strong R&D capabilities and a wide product portfolio catering to different treatment needs. Key Takeaways: The Global Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market Size is expected to witness high growth, exhibiting CAGR of 5. Key players analysis: Key players operating in the cancer chemotherapy associated nausea and vomiting therapeutics market are Johnson & Johnson Services, Inc.

Motion Sickness Patch Market Size, Share, Regional Overview and Global Forecast to 2027

Trivendra Hussain 2021-12-27

The Motion Sickness Patch Market 2021 research report gives emerging industry data, global segments and regional outlook. Get more information on "Global Motion Sickness Patch Market Research Report" by requesting FREE Sample Copy at https://www. Additionally, these tools also give inclusive assessment of each application/product segment in the global market of motion sickness patch. Browse Global Motion Sickness Patch Market Research Report with detailed TOC at https://www. By Application:· Home Use· Business UseBy Type:· Patch For Behind The Ear· Patch For Belly Button· OthersRegional AnalysisThis section covers regional segmentation which accentuates on current and future demand for motion sickness patch market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

Motion Sickness Patch Market Size, Key Players & Forecast Report to 2030

Aniqa Sheikh 2023-06-23

Moreover, the report also highlights a sudden occurrence of COVID-19 impact on Motion Sickness Patch market to improve future capacities and other developments. The entire motion sickness patch market has been sub-categorized into application and type. Request a FREE Sample Copy of Global Motion Sickness Patch Market Report with Full TOC At: https://www. The major players in the motion sickness patch market include YUNNANBAIYAO, Qingdao, Qianjiang Biological Engineering, Sumifun Industries, Henan Kangdi Medical Devices, HAINUO, CVS Health, and Prestige Consumer Healthcare. Browse Full Global Motion Sickness Patch Market Research Report With TOC At: https://www.

Nausea Medicine Market Driven by High Prevalence of Diseases Causing Nausea

Omkar Patel 2024-01-19

The global nausea medicine market is estimated to be valued at US$ 2. The global nausea medicine market is witnessing high growth owing to increasing prevalence of diseases causing nausea like cancer, gastrointestinal infections, liver diseases, and morning sickness during early pregnancy stages. SWOT Analysis Strength: The nausea medicine market has several established branded drugs with strong brand recognition and loyalty. Key Takeaways The global nausea medicine market is expected to witness high growth over the forecast period driven by rising cancer incidence worldwide requiring chemotherapy treatments. Key players: Key players operating in the nausea medicine market include GlaxoSmithKline plc, Pfizer Inc.

Nausea Medicine Market – Global Industry Key Trends, Competitive Scenario, Current and Future Players

Ruchita Roy 2020-12-29

Market HighlightsNausea is a distress in stomach with involuntary urge to vomit which may be due to number of indications such as gastrointestinal diseases such as stomach upset, gastric ulcers.

Furthermore, chemotherapy induced nausea is less common than other symptoms such as gastric reflux.

Nausea is found to be common among children and pregnant women.

The global nausea medicine market is expected to grow at a CAGR of 7.2% during the forecast period.

Taste the market data and market information presented through more than 120 market data tables and figures spread over 200 pages of the project report.

According to an article published in the journal of Clinical Virology, in Europe, acute infectious gastroenteritis is one of the major causes for substantial morbidity and economic loss.Asia Pacific is the fastest growing market for nausea medicine due to lifestyle changes and unhealthy diet.

Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Size, Share, Regional Overview and Global Forecast to 2028

Faisal Gocher 2022-04-30

The major players in the chemotherapy-induced nausea and vomiting therapeutics market include GlaxoSmithKline plc, Merck & Co. Get more information on "Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report" by requesting FREE Sample Copy at https://www. Additionally, these tools also give an inclusive assessment of each segment in the global market of chemotherapy-induced nausea and vomiting therapeutics. Browse Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report with detailed TOC athttps://www. Purchase Complete Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report athttps://www.

WHO TO FOLLOW

MORE FROM AUTHOR

Open source CRM software: Short Summary

Lucy Kart 2024-03-26

Next Generation Probiotics: Rising Significance of Health and Wellness

Lucy Kart 2024-03-22

Shavers - An Essential Grooming Tool

Lucy Kart 2024-03-22

The Rapid Rise of Europe E-bikes

Lucy Kart 2024-03-20

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Size, Industry Share Forecast

Hayaat Khanam 2023-09-01

The global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast. The major players in the chemotherapy-induced nausea and vomiting therapeutics market include GlaxoSmithKline plc, Merck & Co. Get more information on "Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report" by requesting FREE Sample Copy at https://www. Browse Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report with detailed TOC athttps://www. Purchase Complete Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report athttps://www.

Nausea Medicine Market Is Estimated To Witness High Growth Owing

Poonam 2023-10-10

The global nausea medicine market is estimated to be valued at US$ 7. In conclusion, the global nausea medicine market is projected to witness high growth due to the increasing prevalence of nausea and vomiting, especially in cancer patients undergoing chemotherapy. Increased awareness of the benefits of nausea medicine and a growing aging population can contribute to market growth. Technological: The technological factors influencing the nausea medicine market include advancements in drug delivery systems, research and development, and telemedicine. In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the nausea medicine market.

Precision Medicine vs. Personalized Medicine: What's the Difference?

Shivani 2022-02-28

Precision medicine is "an emerging strategy for illness treatment and prevention that takes into account individual heterogeneity in genes, environment, and lifestyle for each person," according to the Precision Medicine Initiative. Doctors and researchers will be able to anticipate more correctly whether treatment and prevention methods for a specific disease will work in which groups of people using this approach. Read more @ https://tradove. com/blog/What-Is-the-Difference-Between-Precision-Medicine-and-Personalized-Medicine. html

Regenerative Medicine: Building a New Era of Healing

Larry Paige 2023-07-05

It represents a paradigm shift in healthcare, moving away from traditional symptomatic treatments and offering innovative approaches for long-lasting solutions. Through the use of stem cell therapy, tissue engineering, and gene therapy, it holds tremendous promise. Stem cells possess the remarkable ability to differentiate into various cell types, making them invaluable for regenerating specific tissues. As research and technological advancements progress, it is unlocking new possibilities for personalized treatments, accelerating the healing process, and transforming healthcare. It represents a transformative approach that brings hope to patients and opens up new avenues for regaining health and well-being.

Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market Is Estimated To Witness High Growth Owing To Increasing Demand For Efficient Nausea

Anjali CMI 2023-09-08

The global Cancer Chemotherapy Associated Nausea and Vomiting (CINV) therapeutics market is estimated to be valued at US$3,071. In order to manage these symptoms effectively, the demand for CINV therapeutics is increasing. This has led to various initiatives aimed at reducing the financial burden on cancer patients and promoting research and development in the field. Economic: The increasing prevalence of cancer globally, coupled with rising healthcare expenditure, is driving the demand for CINV therapeutics. In conclusion, the global market for Cancer Chemotherapy Associated Nausea and Vomiting (CINV) therapeutics is projected to experience significant growth over the forecast period.

Using Medical Cannabis & CBD for Patients with Cancer

Halso 2021-11-23

Analgesia or Pain ReliefMost cancer patients experience pain of some sort. In the study, "Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain", Johnson et al use a randomized controlled trial to study the impact of THC:CBD extract, THC extract, or placebo on pain for cancer patients. Based on this finding, Johnson et al recommended the use of this THC:CBD extract for pain relief for advanced cancer patients when traditional opioids don't work. As a speculative side note, the THC:CBD extract may have worked when the THC alone did not work because of the entourage effect of full spectrum CBD. Thus, the THC:CBD extract may be interacting together to cause the entourage effect where the THC could not work individually.

Aesthetic Medicine Market is Estimated to Witness High Growth

Sneha 2024-01-17

The global Aesthetic Medicine Market is estimated to be valued at US$ 147. 9 Bn in 2023 and is expected to exhibit a CAGR of 5. Furthermore, rising disposable incomes have facilitated affordability of these aesthetic treatments. Porter's AnalysisThreat of new entrants: The high level of competition in the aesthetic medicine market poses a significant threat as new entrants face high capital investment in equipment and expertise. The global Aesthetic Medicine Market is estimated to be valued at US$ 147. 9 Bn in 2023 and is expected to exhibit a CAGR of 5. Key players operating in the aesthetic medicine market are Johnson & Johnson, Lumenis, Cynosure, Allergan, Alma Lasers, Solta Medical, Cutera, and Syneron Medical.

Chemotherapy-Induced Nausea and Vomiting Therapeutics Market 2020 Major Key Players and Industry Analysis Till 2027

Kanikasharma 2021-05-28

Chemotherapy-Induced Nausea and Vomiting Therapeutics Market report published by Value Market Research, which studies the future outlook of the market.

It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the chemotherapy-induced nausea and vomiting therapeutics market include GlaxoSmithKline plc, Merck & Co., Inc, Teva Pharmaceuticals, Heron Therapeutics, Inc., F. Hoffmann-La Roche AG, Tesaro, Inc., Acacia Pharma, Baxter international Inc., Lee's Pharmaceutical Holdings, Mundipharma International limited, Kyowa Hakko Kirin Co., Ltd.

This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Chemotherapy-Induced Nausea and Vomiting Therapeutics Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/chemotherapy-induced-nausea-and-vomiting-therapeutics-market/download-sampleMarket DynamicsRising cancer prevalence, a growing number of patients undergoing chemotherapy, expanding healthcare infrastructure, and a high success rate of therapies are factors accelerating the demand for nausea and vomiting drugs induced by chemotherapy.

As per World Health Organization (WHO) estimates, cancer is a leading cause of death worldwide, accounting for nearly 10 million new cases in 2020.

Easing the health insurance process, expanding the number of cancer specialist hospitals worldwide, and growing life expectancy is causing a rise in the number of chemotherapies performed, propelling the market growth.

Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Is Estimated To Witness High Growth Owing To Growing Number Of Chemotherapy Treatment Cases

Ashish Thapa 2024-01-25

The global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market is estimated to be valued at US$ 3537. According to the International Agency for Research on Cancer (IARC), the number of new cancer cases around the world is expected to rise by over 70% by 2040. Porter’s Analysis Threat of new entrants: The threat of new entrants is moderate as the Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics market requires high R&D investment and strict regulatory approvals. Key Takeaways The global Cancer Chemotherapy Associated Nausea And Vomiting Therapeutics Market Size is expected to witness high growth. The global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market is estimated to be valued at US$ 3537. Key players operating in the Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics market are Nature Essential Foods Pvt Ltd, Lotus Bakeries, General Mills Inc.

Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Growth 2019-2024

naresh pawar 2019-05-20

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments.

Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others.

The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%.Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are application for Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy and others.

The most of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is used for Moderately Emetogenic Chemotherapy, and the market share of that is about 52 % in 2017.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-chemotherapy-induced-nausea-vomiting-drugs-2019-2024-58According to this study, over the next five years the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will register a 5.9% CAGR in terms of revenue, the global market size will reach US$ 96 million by 2024, from US$ 72 million in 2019.

In particular, this report presents the global market share (sales and revenue) of key companies in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs business, shared in Chapter 3.This report presents a comprehensive overview, market shares, and growth opportunities of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by product type, application, key manufacturers and key regions and countries.This study considers the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs value and volume generated from the sales of the following segments:Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.5-HT3 InhibitorsNK1 InhibitorsOtherSegmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.Highly Emetogenic ChemotherapyModerately Emetogenic ChemotherapyLow Emetogenic ChemotherapyOtherThis report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapanKoreaSoutheast AsiaIndiaAustraliaEuropeGermanyFranceUKItalyRussiaSpainMiddle East & AfricaEgyptSouth AfricaIsraelTurkeyGCC CountriesThe report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.

The key manufacturers covered in this report: Breakdown data in in Chapter 3.MerckEisaiMundipharmaQilu PharmaTevaNovartisHeron TherapeuticsRocheMylanTesaroResearch objectives:To study and analyze the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market by identifying its various subsegments.Focuses on the key global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-chemotherapy-induced-nausea-vomiting-drugs-2019-2024-58Table of content1 Scope of the Report1.1 Market Introduction1.2 Research Objectives1.3 Years Considered1.4 Market Research Methodology1.5 Economic Indicators1.6 Currency Considered2 Executive Summary2.1 World Market Overview2.1.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption 2014–20242.1.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption CAGR by Region2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Type2.2.1 5-HT3 Inhibitors2.2.2 NK1 Inhibitors2.2.3 Other2.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Type2.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Market Share by Type (2014–2019)2.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue and Market Share by Type (2014–2019)2.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sale Price by Type (2014–2019)2.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Segment by Application2.4.1 Highly Emetogenic ChemotherapyCONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store/

Veterinary Oncology Is Fastest Growing Segment Fueling Growth of Veterinary Oncology Market

Lucy Kart 2023-12-12

The global Veterinary Oncology Market is estimated to be valued at US$ 657. Segment Analysis The global veterinary oncology market is segmented into therapy, animal type, and end user. Among these, the chemotherapy segment dominates the global veterinary oncology market owing to its wide applications. Key Takeaways Global Veterinary Oncology Market Demand is expected to witness high growth, exhibiting CAGR of 8. holds the dominant share in the global veterinary oncology market owing to its wide product portfolio and strong geographical presence across the globe.

Nausea Medicine Evolution: Advancements in Treatment

Roger 2024-02-23

Some of the most common and effective OTC anti-nausea medicines include:- Dramamine: Dramamine is an antihistamine that helps prevent and treat nausea, vomiting, and dizziness. Look for ginger as slices, ground ginger, ginger ale, ginger candy or capsules. - Sea-Bands: Sea-Bands are acupressure wrist bands with a button that applies gentle pressure to an acupressure point on the inner wrist linked to nausea relief. GlucocorticoidsDexamethasone and methylprednisolone are corticosteroids that help reduce inflammation and nausea from conditions like food poisoning or cancer treatment. - Aromatherapy: The scent of peppermint, ginger, or lavender essential oils is sometimes calming and can relieve nausea.

Compounding Chemotherapy Market is Anticipated to Witness Moderate Growth Owing to Rising Prevalence of Cancer

Niranjan Mardakar 2024-02-22

The compounding chemotherapy market is comprised of pharmaceutical services and sterile preparations of customized chemotherapy regimens in specific drug dosages, combinations, and volumes. The rising prevalence of various types of cancer such as breast cancer, lung cancer, prostate cancer and colorectal cancer globally has increased the demand for chemotherapy as one of the major treatment options. 9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States in 2022. The global compounding chemotherapy market is estimated to be valued at US$ 11. Based on therapeutic area, the market is categorized into lung cancer, breast cancer, ovarian cancer, leukemia, lymphoma and others.

Global Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Report 2021

vivek bajaj 2021-07-17

The global Chemotherapy-Induced Nausea and Vomiting Drugs market is segmented by company, region (country), by Type, and by Application.

Players, stakeholders, and other participants in the global Chemotherapy-Induced Nausea and Vomiting Drugs market will be able to gain the upper hand as they use the report as a powerful resource.

The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by TypeDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-chemotherapyinduced-nausea-vomiting-drugs-2021-715 Existing DrugsAkynzeo (Netupitant-Palonosetron FDC)Aloxi (Palonosetron)Emend (Aprepitant)Kytril Generic (Granisetron)Zofran Generic (Ondansetron)Pipeline DrugsSUSTOL (Granisetron Injection extended release)Rolapitant Segment by Application Serotonin Receptor AntagonistsNK1 Receptor Antagonists The Chemotherapy-Induced Nausea and Vomiting Drugs market is analysed and market size information is provided by regions (countries).

Segment by Application, the Chemotherapy-Induced Nausea and Vomiting Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company Merck & Co., Inc.GlaxoSmithKline plcTesaro, Inc.Helsinn GroupF.